Picture EBD Group BIO-Europe 2021 Time to Register 650x100
Document › Details

VeroVaccines GmbH. (7/17/17). "Press Release: VeroVaccines GmbH Founded in Halle (Saale), Germany".

Region Region Halle (Saale)
  Country Germany
Organisations Organisation VeroVaccines GmbH
  Organisation 2 BMBF (Federal Ministry for Education and Research) (DE)
  Group Germany (govt)
Products Product animal vaccine
  Product 2 business development (state/region)
Persons Person Hennemann, Hanjo (VeroVaccines GmbH 201707– Managing Direcotor + Co-Founder before Nexigen GmbH)
  Person 2 Behrens, Sven-Erik (Univ Halle 201805 Professor + VeroVaccines GmbH 201805 Managing Director + Co-Founder)

VEROVACCiNES GmbH is a successful spin-off from the Martin Luther University Halle-Wittenberg, Germany. The co-founders Dr. Hanjo Hennemann and Prof. Dr. Sven-Erik Behrens entered the management of the company as managing directors.

“We are very pleased to get the company started. After achieving a positive votum for our funding application in the federal BMBF GO-Bio-funding program, making VEROVACCiNES eligible for 3.1 m euros funding, it made sense to get the company off the ground. We plan to close the financing round soon and to continue the development of our vaccine programs.” Dr. Hanjo Hennemann said.

Record changed: 2021-10-14


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for VeroVaccines GmbH

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top